Skip to main navigation Skip to search Skip to main content

A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory myopathies

Project: Research project

Project Details

StatusActive
Effective start/end date5/26/26 → 5/25/36

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION